share_log

Lake Street Downgrades Silk Road Medical to Hold, Lowers Price Target to $27.5

Lake Street Downgrades Silk Road Medical to Hold, Lowers Price Target to $27.5

Lake Street將silk road medical的評級降爲持有,將價格目標下調至$27.5。
Benzinga ·  06/18 17:42

Lake Street analyst Frank Takkinen downgrades Silk Road Medical (NASDAQ:SILK) from Buy to Hold and lowers the price target from $28 to $27.5.

Lake Street分析師Frank Takkinen將Silk Road Medical (納斯達克:silk road medical)的評級從買入下調至持有,並將價格目標從28美元下調至27.5美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論